FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 297:132-135 July 21, 1977 Number 3 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We attempted to define the substances that contribute to the characteristic "uremic breath" of patients with end-stage renal disease. Breath samples from nine patients underwent direct analysis before and after hemodialysis with use of gas chromatography and confirmation by mass spectrometry, and indirectly assessment by an organoleptic panel. Concentrations of secondary and tertiary amines, dimethylamine and trimethylamine were increased, with subsequent reduction after hemodialysis (dimethylamine from 2.00 +/- 0.19 [S.E.M.] to 0.88 +/- 0.12 microng per 30 minutes, P less than 0.001, and trimethylamine from 0.79 +/- 0.22 to 0.44 +/- 0.15 microng per 30 minutes, P less than 0.003). Treatment with nonabsorbable antibiotics in two patients reduced both serum and breath amine levels without dialysis. Loss of nitrogen via the breath was not quantitatively important. We conclude that uremic breath reflects the systemic accumulation of potentially toxic volatile metabolites, among which dimethylamine and trimethylamine have been positively identified and correlated with the classic fishy odor.

This article has been cited by other articles:

• SPONRING, A., FILIPIAK, W., MIKOVINY, T., AGER, C., SCHUBERT, J., MIEKISCH, W., AMANN, A., TROPPMAIR, J. (2009). Release of Volatile Organic Compounds from the Lung Cancer Cell Line NCI-H2087 In Vitro. Anticancer Res 29: 419-426 [Abstract] [Full Text]  
• Meyer, T. W., Hostetter, T. H. (2007). Uremia. NEJM 357: 1316-1325 [Full Text]  
• Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., Evans, A. M. (2006). Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 21: 1300-1304 [Abstract] [Full Text]  
• Schreiber, B. (2005). Levocarnitine and Dialysis: A Review. Nutr Clin Pract 20: 218-243 [Abstract] [Full Text]  
• Schiffman, S. S., Williams, C. M. (2005). Science of Odor as a Potential Health Issue. J. Environ. Qual. 34: 129-138 [Abstract] [Full Text]  
• Lirk, P., Bodrogi, F., Raifer, H., Greiner, K., Ulmer, H., Rieder, J. (2003). Elective haemodialysis increases exhaled isoprene. Nephrol Dial Transplant 18: 937-941 [Abstract] [Full Text]  
• Kopple, J. D. (1987). Uses and Limitations of the Balance Technique. JPEN J Parenter Enteral Nutr 11: 79S-85S [Abstract]  
• GOLDBLUM, S. E., REED, W. P. (1980). Host Defenses and Immunologic Alterations Associated with Chronic Hemodialysis. ANN INTERN MED 93: 597-613 [Abstract]